Author:
Viermyr Hans-Kittil,Tonby Kristian,Ponzi Erica,Trouillet-Assant Sophie,Poissy Julien,Arribas José Ramon,Dyon-Tafani Virginie,Bouscambert-Duchamp Maude,Assoumou Lambert,Halvorsen Bente,Basdag Tekin Nuriye,Diallo Alpha,De Gastines Lucie,Munthe Ludvig André,Murphy Sarah,Ueland Thor,Michelsen Annika E.,Lund-Johansen Fridtjof,Aukrust Pål,Mootien Joy,Dervieux Benjamin,Zerbib Yoann,Richard Jean-Christophe,Prével Renaud,Malvy Denis,Timsit Jean Francois,Peiffer-Smadja Nathan,Roux Damien,Piroth Lionel,Ait-Oufella Hafid,Vieira Cesar,Dalgard Olav,Heggelund Lars,Müller Karl Erik,Møller Jannicke Horjen,Kildal Anders Benjamin,Skogen Vegard,Aballi Saad,Sjøberg Øgaard Jonas Daniel,Dyrhol-Riise Anne Ma,Tveita Anders Aune,Alirezaylavasani Amin,Costagliola Dominique,Yazdanpanah Yazdan,Olsen Inge Christoffer,Dahl Tuva Børresdatter,Kared Hassen,Holten Aleksander Rygh,Trøseid Marius
Reference45 articles.
1. grants for developing cellular analyses of COVID-19 (2020-2022) and Grant from CEPI to monitor immune responses in patients (2021-2023);DC reports an HIV grant from Janssen,2019
2. The cytokine storm and COVID-19;B Hu;J Med Virol,2021
3. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease;P Richardson;Lancet,2020
4. Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach;Y Tanaka;Nat Rev Rheumatol,2022
5. A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia;Y Tanaka;Inflamm Regen,2023